BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4008800)

  • 1. Theophylline and fibrocystic breast disease.
    Hindi-Alexander MC; Zielezny MA; Montes N; Bullough B; Middleton E; Rosner DH; London WM
    J Allergy Clin Immunol; 1985 Jun; 75(6):709-15. PubMed ID: 4008800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biochemical studies on methylxanthine-related fibrocystic breast disease.
    Minton JP; Abou-Issa H; Reiches N; Roseman JM
    Surgery; 1981 Aug; 90(2):299-304. PubMed ID: 7256542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylxanthines and fibrocystic breast disease: a study of correlations.
    Bullough B; Hindi-Alexander M; Fetouh S
    Nurse Pract; 1990 Mar; 15(3):36-8, 43-4. PubMed ID: 2314678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylxanthines and benign proliferative epithelial disorders of the breast in women.
    Rohan TE; Cook MG; McMichael AJ
    Int J Epidemiol; 1989 Sep; 18(3):626-33. PubMed ID: 2681017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coffee consumption and fibrocystic breasts: an unlikely association.
    Heyden S; Fodor JG
    Can J Surg; 1986 May; 29(3):208-11. PubMed ID: 3708462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonassociation of caffeine and fibrocystic breast disease.
    Levinson W; Dunn PM
    Arch Intern Med; 1986 Sep; 146(9):1773-5. PubMed ID: 3530165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The toxicology of cocoa and methylxanthines: a review of the literature.
    Tarka SM
    Crit Rev Toxicol; 1982; 9(4):275-312. PubMed ID: 6765610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case-control study of caffeine and methylxanthines in benign breast disease.
    Lubin F; Ron E; Wax Y; Black M; Funaro M; Shitrit A
    JAMA; 1985 Apr; 253(16):2388-92. PubMed ID: 3981766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylxanthines and breast cancer.
    Rohan TE; McMichael AJ
    Int J Cancer; 1988 Mar; 41(3):390-3. PubMed ID: 3346103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen replacement therapy and fibrocystic breast disease in postmenopausal women.
    Berkowitz GS; Kelsey JL; Holford TR; LiVolsi VA; Merino MJ; Beck GJ; Ort S; O'Connor TZ; White C
    Am J Epidemiol; 1985 Feb; 121(2):238-45. PubMed ID: 4014118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutritional profile of women with fibrocystic breast disease.
    Vobecky J; Simard A; Vobecky JS; Ghadirian P; Lamothe-Guay M; Falardeau M
    Int J Epidemiol; 1993 Dec; 22(6):989-99. PubMed ID: 8144312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case-control study of fibrocystic breast disease.
    Simard A; Vobecky J; Vobecky JS; Ghadirian P; Lamothe-Guay M; Falardeau M
    Rev Epidemiol Sante Publique; 1993; 41(1):84-9. PubMed ID: 8465069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety considerations for patients with epilepsy taking antiepileptic drugs alongside caffeine or other methylxanthine derivatives.
    Chrościńska-Krawczyk M; Radzik I; Miziak B; Czuczwar SJ
    Expert Opin Drug Metab Toxicol; 2014 Jul; 10(7):981-9. PubMed ID: 24848690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylxanthines and benign breast disease.
    Schairer C; Brinton LA; Hoover RN
    Am J Epidemiol; 1986 Oct; 124(4):603-11. PubMed ID: 3752054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of "fibrocystic breast disease" and caffeine consumption.
    Heyden S; Muhlbaier LH
    Surgery; 1984 Sep; 96(3):479-84. PubMed ID: 6474353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptive use and fibrocystic breast disease of different histologic classifications.
    Hsieh CC; Crosson AW; Walker AM; Trapido EJ; MacMahon B
    J Natl Cancer Inst; 1984 Feb; 72(2):285-90. PubMed ID: 6582316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer and the consumption of coffee.
    Rosenberg L; Miller DR; Helmrich SP; Kaufman DW; Schottenfeld D; Stolley PD; Shapiro S
    Am J Epidemiol; 1985 Sep; 122(3):391-9. PubMed ID: 4025289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is theophylline, aminophylline, or caffeine (methylxanthines) contraindicated in malignant hyperthermia susceptible patients?
    Flewellen EH; Nelson TE
    Anesth Analg; 1983 Jan; 62(1):115-8. PubMed ID: 6849503
    [No Abstract]   [Full Text] [Related]  

  • 19. Behavioral and cognitive effects of methylxanthines. A meta-analysis of theophylline and caffeine.
    Stein MA; Krasowski M; Leventhal BL; Phillips W; Bender BG
    Arch Pediatr Adolesc Med; 1996 Mar; 150(3):284-8. PubMed ID: 8603222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonendocrine theories of the etiology of benign breast disease.
    Minton JP; Abou-Issa H
    World J Surg; 1989; 13(6):680-4. PubMed ID: 2696219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.